CRYSTALLINE FORM OF (S)-2-(8-((5-CHLOROPYRIMIDIN-2-YL)(METHYL)AMINO)-2-FLUORO-6,7,8,9-TETRAHYDRO-5H-PYRIDO3,2-bINDOL-5-YL)ACETIC ACID AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME

摘要

The invention relates to a new crystalline form of (S)-2-(8-((5-chloropyrimidin-2-yl)(methyl)amino)-2-fluoro-6,7,8,9-tetrahydro-5H-pyrido[3,2-b]indol-5-yl)acetic acid, pharmaceutical compositions comprising such crystalline form, and the use of this crystalline form as medicaments, especially as CRTH2 (chemoattractant receptor-homologous molecule expressed on Th2 cells) receptor modulators.